Analysts’ Opinions Are Mixed on These Services Stocks: Nant Health (NASDAQ: NH) and CVS Health (NYSE: CVS)

By Jason Carr

Analysts have been eager to weigh in on the Services sector with new ratings on Nant Health (NASDAQ: NH) and CVS Health (NYSE: CVS).

Nant Health (NASDAQ: NH)

In a report released today, Brandon Couillard from Jefferies reiterated a Buy rating on Nant Health (NASDAQ: NH), with a price target of $8. The company’s shares opened today at $4.96.

According to TipRanks.com, Couillard is a top 100 analyst with an average return of 17.0% and a 76.7% success rate. Couillard covers the Healthcare sector, focusing on stocks such as Bio-Rad Laboratories, Orasure Technologies, and DENTSPLY SIRONA Inc.

Currently, the analyst consensus on Nant Health is Strong Buy and the average price target is $10.33, representing a 108.3% upside.

In a report issued on March 17, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $15 price target.
CVS Health (NYSE: CVS)

In a report released today, Brian Tanquilut from Jefferies reiterated a Hold rating on CVS Health (NYSE: CVS), with a price target of $82. The company’s shares opened today at $78.50.

According to TipRanks.com, Tanquilut is a 3-star analyst with an average return of 2.4% and a 50.0% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as ACADIA Pharmaceuticals, Five Star Quality Care, and Quest Diagnostics Inc.

CVS Health has an analyst consensus of Strong Buy, with a price target consensus of $86.20.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.